Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1150 MG double-blinded secukinumab----[1] 271 💬
2150 MG OPEN-label secukinumab----[1] 271 💬
3300 MG double-blinded secukinumab----[1] 271 💬
4Secukinumab[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[8] 13, 37, 41, 46, 107, 160, 269, 271 💬
5Secukinumab 150 MG[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 41 💬
6Secukinumab 150 MG (2 injections PER dose[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 269 💬
7Secukinumab 150 MG/1 ML solution FOR injection[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[2] 37, 271 💬
8Secukinumab 150 MG/ML[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 271 💬
9Secukinumab 150MG[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 37 💬
10Secukinumab 300 MG[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 41 💬
11Secukinumab 300MG[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 37 💬
12Secukinumab 75 MG/0.5 ML solution FOR injection[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 271 💬
13Secukinumab injection[1] Secukinumab (Secukinumab)[1] Secukinumab (Secukinumab, Secukinumab) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 160 💬